Pfizer To Invest Half Billion in Sanford Facility
Pfizer announced today an additional half billion dollar investment for the construction of its state-of-the-art gene therapy facility in Sanford, North Carolina. The facility is anticipated to support Pfizer’s continuing investment in gene therapy research and development, similar to Pfizer’s Chapel Hill and Kit Creek research and development sites. The facility will expand the company’s presence in North Carolina, where there are currently more than 3,600 Pfizer colleagues, including 650 in Sanford. The expanded facility is projected to add approximately 300 new jobs.
Pfizer celebrated the successful completion of the first phase of the project at a ceremony today with Governor Roy Cooper and many Sanford officials in attendance.
Pfizer is a 169-year-old company with more than 10,000 US employees in 14 US locations.